NCT00000178

Data

{
  "briefSummary": "This is a randomized placebo controlled, double blind study. Patients who meet eligibility criteria and decide to participate in the study will be randomly assigned to receive either drug treatment or a placebo. Neither the patients nor the participating investigators will know who is receiving the drugs and who is receiving the placebo. Participation involves 15 outpatient clinic visits over a 68 week period. Patients take study medication at varying doses (the maximum dose is 20 mg daily), along with calcium and vitamin supplements.",
  "completionDate": null,
  "conditions": [
    "Alzheimer Disease"
  ],
  "enrollmentCount": null,
  "enrollmentType": null,
  "nctId": "NCT00000178",
  "phase": "PHASE3",
  "sponsorId": "national-institute-on-aging-nia",
  "startDate": null,
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "Multicenter Trial of Prednisone in Alzheimer's Disease",
  "url": "https://clinicaltrials.gov/study/NCT00000178"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version